•  Nitric Oxide
  •  Products
  •  Innovation
  •  Investors
  •  Connect

Nu-Med Plus

  •  Nitric Oxide
  •  Products
  •  Innovation
  •  Investors
  •  Connect

Category: Investor News

Nu-Med Plus Announces Filing of U.S. Provisional Patent Application for Nitric Oxide in Aqueous Solution for Wound Care Treatment

Posted on November 3, 2020November 3, 2020
Posted in Investor News

Protected: Articles

Posted on October 14, 2020October 27, 2020

This content is password protected. To view it please enter your password below:

Posted in Investor News

Patent Issued for Single-Use or Short-Term Nitric Oxide Delivery Device

Posted on July 30, 2020July 30, 2020
Posted in Investor News

What is Nitric Oxide? How the gas that gave us Viagra could help treat Coronavirus patients

Posted on April 7, 2020
Posted in Investor News

Nu-Med Plus Closely Monitoring Outcomes on Two New Human Clinical Trials Using Inhaled Nitric Oxide in Treatment of COVID-19

Posted on April 6, 2020
Posted in Investor News

Patent filed for Nitric Oxide Delivery Device that is comparable to inhalers for single or short-term usage

Posted on January 7, 2020
Posted in Investor News

Nu-Med Plus Presents at the 147th National Investment Banking Association Conference on November 12-13, 2019 in New York City

Posted on December 4, 2019
Posted in Investor News

Nu-Med Plus Reports Spike in International Interest from Physicians, Distributors, and Potential Strategic Partners

Posted on June 18, 2019June 18, 2019
Posted in Investor News

Nu-Med Plus, Inc. Approaches Milestone FDA Application for New Nitric Oxide Medical Device Approval

Posted on June 18, 2019June 18, 2019
Posted in Investor News

Miniaturized Inhaled Nitric Oxide Delivery Units for Use in a Doctor’s Office

Posted on February 8, 2019February 8, 2019
Posted in Investor News

Posts navigation

Older posts

Connect

Jeff Robins | CEO
jeff@nu-medplus.com
801.746.3570
LinkedIn
Twitter

Offices

Corporate 455 E. 500 S.
Suite #203
Salt Lake City UT, 84111

Lab 1266 S 1380 W
Orem UT, 84111

News

Stay Up to Date On Nu-Med Plus News

Legal

SEC Documents Shareholder Letters Privacy Policy

Crunchbase

Profile

© 2021 Nu-Med Plus All Rights Reserved

Site designed + built by Wildern